DOI: 10.1161/CIRCULATIONAHA.119.042375 [Google Scholar] Kosiborod MN, Abildstrom SZ, Borlaug BA, Butler J, Rasmussen S, Davies M, et al
In human breast cancer cells, DADS inhibited TNF--induced release of MCP-1, a chemokine that promotes tissue remodeling, angiogenesis, and metastasis (77)
It should be noted that the the Food and Drug Administration has addressed concerns about unapproved GLP-1 drugs used for weight loss
Combination therapy has also resulted in improved glucoregulation via an increase in insulin sensitivity, an observation that has been linked to the recovery of pancreatic -cell function 21
Tri-Fortify is backed by peer-reviewed, published clinical research
Rapid, standardized handling is therefore essential (Tomin et al., 2020